Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site

Valuation: Abbott Laboratories

Capitalization 202B 192B 179B 159B 284B 17,086B 312B 2,222B 824B 7,006B 758B 741B 30,158B P/E ratio 2024 *
34x
P/E ratio 2025 * 29.3x
Enterprise value 208B 198B 184B 164B 293B 17,633B 321B 2,293B 850B 7,231B 782B 765B 31,122B EV / Sales 2024 *
4.96x
EV / Sales 2025 * 4.6x
Free-Float
86.65%
Yield 2024 *
1.9%
Yield 2025 * 2.01%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.45%
1 week-1.42%
Current month-2.09%
1 month-1.95%
3 months+1.42%
6 months+13.05%
Current year+5.65%
More quotes
1 week
116.07
Extreme 116.07
119.19
1 month
114.43
Extreme 114.43
121.00
Current year
99.71
Extreme 99.71
121.64
1 year
99.71
Extreme 99.71
121.64
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Director TitleAgeSince
Chief Executive Officer 50 30/03/2020
Director of Finance/CFO 51 31/08/2023
Chief Tech/Sci/R&D Officer - 29/02/2020
Manager TitleAgeSince
Director/Board Member 73 09/10/2008
Director/Board Member 62 08/12/2011
Director/Board Member 65 08/12/2011
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.45%-1.42%+10.88%-10.73%202B
-0.96%+0.04%+7.15%-19.80%110B
-0.70%-1.33%-7.13%-9.36%63.97B
+0.07%+0.64%+22.52%+114.16%48.33B
-0.75%+2.58%+21.29%+10.81%46.62B
+2.02%+3.81%-30.62%-37.70%31.6B
0.00%+0.42%+31.90%+34.27%30.69B
-0.24%+0.80%-8.50%-25.85%23.31B
+0.22%+0.09%-6.13%-8.65%22.04B
-1.01%+0.27%+6.46%-1.33%21.38B
Average -0.18%+0.66%+4.78%+4.58% 59.96B
Weighted average by Cap. -0.39%+0.14%+7.37%+0.20%
See all sector performances

Financials

2024 *2025 *
Net sales 42B 39.95B 37.21B 33.17B 59.08B 3,558B 64.86B 463B 172B 1,459B 158B 154B 6,279B 44.98B 42.79B 39.85B 35.52B 63.27B 3,810B 69.46B 496B 184B 1,562B 169B 165B 6,725B
Net income 5.94B 5.65B 5.26B 4.69B 8.35B 503B 9.17B 65.42B 24.25B 206B 22.31B 21.81B 888B 6.85B 6.52B 6.07B 5.41B 9.64B 580B 10.58B 75.48B 27.99B 238B 25.74B 25.17B 1,024B
Net Debt 6.45B 6.14B 5.72B 5.1B 9.08B 546B 9.96B 71.07B 26.35B 224B 24.24B 23.7B 965B 5.08B 4.84B 4.51B 4.02B 7.15B 431B 7.85B 56.02B 20.77B 177B 19.11B 18.68B 760B
More financial data * Estimated data
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Employees
114,000
More about the company
Date Price Change Volume
04/12/24 116.00 $ -0.25% 2,037,852
03/12/24 116.29 $ -0.45% 4,794,886
02/12/24 116.81 $ -1.65% 5,339,311
29/11/24 118.77 $ -0.15% 2,523,194
27/11/24 118.95 $ +0.84% 3,510,309

Delayed Quote Nyse, December 03, 2024 at 09:00 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C+
surperformance-ratings-light-chart ABBOTT-LABORATORIESMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
116.29USD
Average target price
129.87USD
Spread / Average Target
+11.68%
Consensus

Quarterly revenue - Rate of surprise

Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW